Nesfatin-1: what it is and what the evidence says
An endogenous peptide derived from nucleobindin-2, described as a satiety signal in the hypothalamus.
Last reviewed: August 16, 2026 · How we verify this
The ground it plays on
Metabolism is not a single lever. Talk about metabolic compounds usually collapses three separate mechanisms into one word. Appetite regulation is one. How well cells respond to insulin is another, and largely independent of the first. Mobilising stored fat is a third. A compound may act on one and leave the other two untouched, so knowing which one is the difference between understanding a molecule and reciting its name.
What it is studied for
A research target in appetite regulation.
There is a distinction that almost always gets lost. A compound being studied for something is not the same as achieving it. And even where it works in a dish or in a mouse, that says little about whether it works in a person or whether the benefit is worth the risk. The section below therefore carries more weight than everything above it.
What the human evidence says
Nesfatin-1 is NOT an injectable product or a supplement: it is an endogenous peptide discovered in 2006. In humans it is studied as a circulating biomarker and as a physiological target, not as a treatment. No nesfatin-1-based drug has ever been given to people.
The limitation that matters most
All the evidence for its appetite-suppressing effect comes from intracerebral administration in rodents. Its receptor has still not been identified with certainty, which rules out targeted drug development. Any product sold as 'injectable nesfatin-1' has no clinical backing whatsoever.
Regulatory status
It is not a medicine. A subject of physiological research.
Status can change and varies by country. Always verify the rules in force where you live before drawing conclusions.
Cautions and context
It is not an injectable product. Its receptor has not even been identified with certainty.
Runaway appetite or unexplained weight loss is a reason to see a doctor, since a thyroid, digestive or mood-related cause is usually behind it and those can be treated.
What this page cannot give you
A reference page can take you this far. You know what Nesfatin-1 is and where its research stands, which already puts you ahead of most readers. Four questions remain that no encyclopedia can answer for you, because the answers depend on your own situation:
- What would you measure beforehand, so that later you could tell whether anything actually changed?
- What would you watch along the way, and how consistently?
- What would you ask a professional, and in how much detail, so you do not walk out with a textbook answer?
- What would make you stop?
That is what the course is for
PeptiXtreme is ${CIF.LECCIONES} lessons that hand out no numbers. Each one ends with your starting point, what to watch along the way, the specific questions you take to a professional and the signals that mean stop. It includes per-module exams, a diploma with a verifiable folio, a record to track how you progress, and a human advisor you can actually write to.
See the course → Or measure your judgment, freeReferences
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Identification of nesfatin-1 as a satiety molecule in the hypothalamuspreclinical Nature · 2006 · PMID 17036007 →
- NUCB2/nesfatin-1 - Inhibitory effects on food intake, body weight and metabolismreview Peptides · 2020 · PMID 32229144 →
- Interactions between nesfatin-1 and the autonomic nervous system-An overviewreview Peptides · 2022 · PMID 34953946 →
- Role of brain NUCB2/nesfatin-1 in stress and stress-related gastrointestinal disordersreview Peptides · 2023 · PMID 37311488 →
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for Nesfatin-1 or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
Frequently asked questions
What is Nesfatin-1?
An endogenous peptide derived from nucleobindin-2, described as a satiety signal in the hypothalamus. It is studied within the area of metabolic.
Is there human evidence for Nesfatin-1?
Nesfatin-1 is NOT an injectable product or a supplement: it is an endogenous peptide discovered in 2006. In humans it is studied as a circulating biomarker and as a physiological target, not as a treatment. No nesfatin-1-based drug has ever been given to people.
Is it approved by any health agency?
It is not a medicine. A subject of physiological research.
What is the dose of Nesfatin-1?
We do not publish dosages. This is not an oversight. No single figure works for everyone: the regimen depends on a person's medical history, on whatever medication they already take, and on the goal they are chasing, which is something a professional weighs with the case in front of them. What you can build is the ability to walk into that appointment knowing what to ask.
Where can I learn to evaluate this properly?
This page tells you what Nesfatin-1 is and what the evidence says. The PeptiXtreme course teaches the other half: what you would measure before considering anything, what you would watch, the specific questions you would take to a professional and when you would stop.